Pricing Log in Create free account
Saturday 17 October 2026 Export DVA’s income statement to Excel — free account

DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

DaVita Inc. (DVA) Business Profile

Updated before January 2025

Company Overview

DaVita Inc. (NYSE: DVA) is a leading healthcare provider specializing in kidney care and dialysis services. Founded in 1994 and headquartered in Denver, Colorado, DaVita has grown to become one of the largest providers of dialysis services in the United States and globally. The company was initially known as Total Renal Care before rebranding to DaVita, which means “giving life” in Italian, reflecting its mission to improve the quality of life for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).

DaVita operates under the leadership of Javier Rodriguez, who serves as the Chief Executive Officer (CEO). Rodriguez has been instrumental in driving the company’s strategic vision and operational excellence. The company’s leadership team is committed to delivering high-quality care, fostering innovation, and maintaining a patient-centric approach.

Core Business Segments

DaVita’s core business revolves around providing comprehensive kidney care services. The company operates through the following major segments:

1. Dialysis Services

DaVita is a market leader in dialysis services, offering both in-center and home dialysis options. Key offerings include:

  • In-Center Hemodialysis: Providing dialysis treatment at over 2,800 outpatient dialysis centers across the U.S.
  • Home Dialysis: Enabling patients to perform dialysis at home through peritoneal dialysis (PD) or home hemodialysis (HHD).
  • Specialized Care Teams: Offering personalized care plans and support from nephrologists, nurses, and dietitians.

2. Integrated Kidney Care (IKC)

DaVita’s IKC program focuses on holistic care for patients with CKD and ESRD. Services include:

  • Care Coordination: Managing patient care across multiple providers and settings.
  • Chronic Disease Management: Helping patients manage comorbidities such as diabetes and hypertension.
  • Value-Based Care Models: Partnering with payers to improve outcomes and reduce costs.

3. International Operations

DaVita has expanded its footprint globally, operating dialysis centers in over 10 countries, including Brazil, Germany, and China. The company aims to bring its expertise in kidney care to underserved markets worldwide.

4. Ancillary Services

DaVita also provides a range of ancillary services to support its core operations, such as:

  • Laboratory Services: Offering diagnostic testing for kidney-related conditions.
  • Pharmacy Services: Providing medications tailored to the needs of dialysis patients.
  • Clinical Research: Conducting studies to advance kidney care treatments and technologies.

Business Model

DaVita’s business model is centered on delivering high-quality, cost-effective kidney care services. The company generates revenue primarily through:

  • Patient Services Revenue: Payments from government programs like Medicare and Medicaid, as well as private insurers, for dialysis treatments and related services.
  • Capitated Payment Models: Fixed payments per patient under value-based care agreements.
  • International Revenue: Earnings from dialysis centers and partnerships outside the U.S.

DaVita integrates its products and services to provide a seamless patient experience. For example, its home dialysis program combines equipment, supplies, and telehealth support to empower patients to manage their care independently.

Strategic Direction

DaVita is focused on several strategic priorities to drive growth and innovation:

1. Expanding Home Dialysis

The company aims to increase the adoption of home dialysis by investing in patient education, training programs, and advanced technologies.

2. Enhancing Value-Based Care

DaVita is committed to expanding its value-based care initiatives, which align incentives with patient outcomes and cost savings.

3. Global Expansion

DaVita plans to grow its international presence by entering new markets and forming strategic partnerships.

4. Sustainability Goals

The company has set ambitious sustainability targets, including reducing its carbon footprint and improving water conservation in its dialysis centers.

5. Innovation in Kidney Care

DaVita continues to invest in research and development to advance treatments, improve patient outcomes, and enhance operational efficiency.

Competitive Landscape

DaVita operates in a competitive healthcare market, facing challenges from:

  • Fresenius Medical Care: A global leader in dialysis services and products.
  • U.S. Renal Care: A major provider of dialysis services in the U.S.
  • Satellite Healthcare: A nonprofit organization offering dialysis and CKD care.
  • Healthcare Systems: Hospitals and integrated health systems that provide dialysis services.

DaVita differentiates itself through its scale, patient-centric approach, and focus on innovation.

Risk Factors

DaVita faces several risks that could impact its business:

  • Regulatory Changes: Changes in Medicare reimbursement rates or healthcare policies could affect revenue.
  • Market Dependence: Reliance on government programs for a significant portion of revenue.
  • Supply Chain Disruptions: Challenges in sourcing dialysis equipment and supplies.
  • Competition: Intense competition from other dialysis providers and healthcare systems.
  • Global Risks: Economic and political instability in international markets.

Recent Developments

1. Expansion of Home Dialysis

DaVita has launched new initiatives to promote home dialysis, including virtual training programs and partnerships with technology providers.

2. Value-Based Care Agreements

The company has entered into new value-based care contracts with payers, aiming to improve patient outcomes and reduce costs.

3. Sustainability Initiatives

DaVita has made progress on its environmental goals, such as reducing energy consumption and implementing water-saving technologies in its centers.

4. COVID-19 Response

DaVita has adapted its operations to ensure patient safety during the pandemic, including enhanced infection control measures and telehealth services.

Investment Considerations

Strengths

  • Market Leadership: DaVita is a leading provider of dialysis services with a strong brand and extensive network.
  • Growth Opportunities: Expanding home dialysis and international operations offer significant growth potential.
  • Value-Based Care Expertise: Proven track record in managing value-based care programs.

Risks

  • Regulatory Uncertainty: Dependence on government reimbursement programs poses risks.
  • Competitive Pressure: Intense competition in the dialysis market.
  • Operational Challenges: Managing a large network of centers and global operations.

Conclusion

DaVita Inc. is a market leader in kidney care, with a strong focus on innovation, patient outcomes, and operational excellence. The company is well-positioned to capitalize on growth opportunities in home dialysis, value-based care, and international markets. However, it faces challenges such as regulatory risks and competitive pressures. Overall, DaVita’s commitment to improving patient care and advancing kidney health makes it a compelling player in the healthcare industry.